The honor comes after decades of work by Weissman and Karikó, whose scientific findings helped make mRNA vaccines—including the Pfizer/BioNTech SARS-CoV-2 vaccine that recently received full FDA approval—a reality. In 2005, they published research that found how mRNA could be altered in order to use it as a therapeutic. Weissman and Kariko changed the way the mRNA was made by including specific naturally occurring mRNA modifications that make the mRNA safer, more stable, and effective for prophylactic and therapeutic purposes.
“Collectively, The Albany Prize recipients have made major contributions to science over decades as researchers, mentors, and educators,” said Vincent P. Verdile, MD, the Lynne and Mark Groban, MD ’67, Distinguished Dean of Albany Medical College and Chair of The Albany Prize National Selection Committee. “Their years of work, scientific expertise, and sheer determination played a critical role in accelerating the development of two mRNA Covid-19 vaccines. And their dedication exemplifies The Albany Prize legacy to honor scientists whose work has demonstrated significant outcomes for the betterment of humankind.”
Along with Weissman and Karikó, Barney S. Graham, MD, PhD, deputy director of the Vaccine Research Center and the chief of the Viral Pathogenesis Laboratory at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, is also a 2021 Albany Prize recipient for RNA research.
The first Albany Prize was bestowed in 2001. Past recipients include Penn’s Carl June, MD, the Richard W. Vague Professor in Immunotherapy, who was honored in 2018 for his work in pioneering the development of CAR T therapy for cancer. This year’s winners will be celebrated at a ceremony in Albany, New York, on September 22, 2021.
Weissman and Kariko have been honored with multiple national and international awards this year, including the Princess of Asturias Award.